ACTU
Actuate Therapeutics, Inc. Common stock
NASDAQ: ACTU · HEALTHCARE · BIOTECHNOLOGY
$2.88
-0.69% today
Updated 2026-04-29
Market cap
$68.29M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.06
Dividend yield
—
52W range
$2 – $12
Volume
0.1M
Actuate Therapeutics, Inc. Common stock (ACTU) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-554.00%
ROA
-120.40%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2022 | $0.00 | $-20.16M | — | — | — |
| 2023 | $0.00 | $-24.74M | — | — | — |
| 2024 | $0.00 | $-27.29M | — | — | — |
| 2025 | $0.00 | $-22.23M | — | — | — |